UK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic ...

Scarless transoral thyroidectomy or transoral vestibular approach (TOVA) allows for the safe and total removal of the thyroid or parathyroid glands with absolutely no external scarring to the neck. Of ...

Hypoparathyroidism means your body doesn't have enough parathyroid hormone (PTH). PTH is made in your parathyroid glands, four pea-sized lobes in your neck. PTH controls calcium, so you'll ...

AstraZeneca's eneboparatide met its Phase 3 trial goal for chronic hypoparathyroidism, while the EU approved Imfinzi for ...

The Thyroid & Parathyroid Center at Baylor Medicine is a world-class medical facility in Houston, TX, where patients can be seen simultaneously by a surgeon and endocrinologist for treatment of both ...

Eneboparatide is an investigational parathyroid hormone (PTH) receptor 1 agonist. By binding to a specific conformation of the PTH receptor 1, eneboparatide is expected to restore PTH function and ...

Objective: We hypothesized that most patients with 22q11.2 deletion and a history of hypocalcemia have inadequate parathyroid function, manifested by intact parathyroid hormone levels below normal.

Günther et al. investigated parathyroid function using knockout mice that are deficient in the transcription factor Gcm2 (ref. 1). Gcm2 stands for “glial cells missing-2” because disruption ...

5,6 It is an endocrine disorder in which the production of parathyroid hormone (PTH) by the parathyroid glands is abnormally low or absent, causing low levels of calcium (hypocalcaemia ...

Completion of enrollment in our Phase 2 trial in HP marks a significant milestone for MBX and brings us closer to our goal of delivering a long-acting PTH therapy designed to treat the underlying ...